Medicine and Dentistry
Ankle Brachial Index
100%
Therapeutic Procedure
88%
Population
75%
Placebo
73%
Cognition
57%
Varices
54%
Venous Ulcer
54%
Acetylsalicylic Acid
53%
Odds Ratio
50%
Artery
44%
Drug
43%
Chemotherapeutic Agent
43%
Randomized Controlled Trial
43%
Intermittent Claudication
42%
Man
39%
Follow up
37%
Age
37%
Cardiovascular System
36%
Smoking
36%
Raynaud Phenomenon
36%
Cognitive Defect
36%
Vasodilator Agent
36%
Ischemic Heart Disease
36%
Deterioration
36%
Association
34%
Atherosclerosis
33%
Woman
32%
Drug Therapy
28%
Peripheral Vascular Disease
28%
Walking Distance
27%
Lower Limb
22%
Venous Thromboembolism
22%
Senescence
22%
Deep Vein Thrombosis
22%
Symptom
22%
Arteriosclerosis Obliterans
21%
Stenting
21%
Angioplasty
21%
Primary Prevention
20%
Cardiovascular Risk
19%
Analysis
18%
Genome Wide Association Study
18%
D-Dimer
18%
Person
18%
Clinical Prediction Rule
18%
Hip Replacement
18%
Hospital Outpatient
18%
Antithrombotic
18%
Knee Replacement
18%
Maturity Onset Diabetes of the Young
18%
Nursing and Health Professions
Placebo
80%
Intermittent Claudication
60%
Ankle Brachial Index
60%
Confidence Interval
58%
Compression Stocking
54%
Varicosis
54%
Population
54%
Ulcer
54%
Woman
48%
Alka-Seltzer
42%
Drug
39%
Odds Ratio
37%
Raynaud Phenomenon
36%
Vasodilator Agent
36%
Prevention
36%
Cognitive Defect
36%
Man
33%
Deterioration
30%
Follow up
28%
Symptom
23%
Venous Thromboembolism
22%
Deep Vein Thrombosis
22%
Patient
22%
Inpatient
21%
Walking Distance
20%
Pressure
19%
Anticoagulant Agent
18%
Atherosclerosis
18%
Adult
18%
Older Adult
18%
Total Knee Arthroplasty
18%
Hypertension
18%
Clinical Prediction Rule
18%
D Dimer
18%
Diagnosis
18%
Hypercholesterolemia
18%
Low Drug Dose
18%
Rey Auditory Verbal Learning Test
18%
Total Hip Prosthesis
18%
Hip Fracture
18%
Drug Therapy
13%
Analysis
13%
Side Effect
13%
Verbal Fluency Test
12%
Person
12%
Hazard Ratio
12%
Beraprost
12%
Moxisylyte
12%
Calcium Channel Blocking Agent
12%
Captopril
12%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
64%
Intermittent Claudication
56%
Acetylsalicylic Acid
38%
Randomized Controlled Trial
38%
Raynaud Phenomenon
36%
Vasodilator Agent
36%
Drug
33%
Atherosclerosis
25%
Calcium Channel Blocker
24%
Non Insulin Dependent Diabetes Mellitus
21%
Deterioration
21%
Anticoagulant Agent
20%
Heart Infarction
19%
Smoke
18%
Venous Thromboembolism
18%
Cognitive Defect
18%
Fibrinogen
18%
Hip Fracture
18%
Hypertension
18%
Hypercholesterolemia
18%
Cilostazol
18%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Group Trial
12%
Beraprost
12%
Moxisylyte
12%
Adverse Event
12%
Captopril
12%
Clinical Trial
11%
Oxidoreductase
10%
Side Effect
9%
Bleeding
8%
Pain
8%
Peripheral Vascular Disease
8%
Low Density Lipoprotein Cholesterol
7%
Symptom
7%
Ketanserin
6%
Enalapril
6%
Dazoxiben
6%
Buflomedil
6%
Prevalence
6%
Elevated Blood Pressure
6%
Dementia
6%
Cholesterol
6%
Etiology
6%
Cardiovascular Risk
6%
Heparin
5%
Death
5%
Insulin
5%
Glucose
5%
